José Luis Ayuso-Mateos

José Luis Ayuso-Mateos

Auto-generated profile, based on publicly available information

José Luis Ayuso-Mateos

Autonomous University of Madrid

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2004 in The British Journal of Psychiatry
Verified
Journal Article
Closed access
PDF file
TÜT. B. Üstün
T. B. Üstün
JAJ. L. Ayuso-Mateos
J. L. Ayuso-Mateos
SCS. Chatterji
S. Chatterji
CMC. Mathers
C. Mathers
CMC. J. L. Murray
C. J. L. Murray
Background: The initial Global Burden of Disease study found that depression was the fourth leading cause of disease burden, accounting for 3.7% of total disability adjusted life years (DALYs) in the world in 1990.Aims: To present the new estimates of depression burden for the year 2000.Method: DALYs for depressive disorders in each world region were calculated, based on new estimates of mortality, prevalence, incidence, average age at onset, duration and disability severity.Results: Depression is the fourth leading cause of disease burden, accounting for 4.4% of total DALYs in the year 2000, and it causes the largest amount of non-fatal burden, accounting for almost 12% of all total years lived with disability worldwide.Conclusions: These data on the burden of depression worldwide represent a major public health problem that affects patients and society.

1 January 2007 in Clinical Practice & Epidemiology in Mental Health
Verified
Journal Article
Open access
PDF file
ARAdriane R Rosa
Adriane R Rosa
JSJose Sánchez-Moreno
Jose Sánchez-Moreno
AMAnabel Martinez-Aran
Anabel Martinez-Aran
MSManel Salamero
Manel Salamero
CTCarla Torrent
Carla Torrent
Eduard VietaEduard Vieta
Eduard Vieta
Numerous studies have documented high rates of functional impairment among bipolar disorder (BD) patients, even during phases of remission. However, the majority of the available instruments used to assess functioning have focused on global measures of functional recovery rather than specific domains of psychosocial functioning. In this context, the Functioning Assessment Short Test (FAST) is a brief instrument designed to assess the main functioning problems experienced by psychiatric patients, particularly bipolar patients. It comprises 24 items that assess impairment or disability in six specific areas of functioning: autonomy, occupational functioning, cognitive functioning, financial issues, interpersonal relationships and leisure time. 101 patients with DSM-IV TR bipolar disorder and 61 healthy controls were assessed in the Bipolar Disorder Program, Hospital Clinic of Barcelona. The psychometric properties of FAST (feasibility, internal consistency, concurrent validity, discriminant validity (euthymic vs acute patients), factorial analyses, and test-retest reliability) were analysed. The internal consistency obtained was very high with a Cronbach's alpha of 0.909. A highly significant negative correlation with GAF was obtained (r = -0.903; p < 0.001) pointing to a reasonable degree of concurrent validity. Test-retest reliability analysis showed a strong correlation between the two measures carried out one week apart (ICC = 0.98; p < 0.001). The total FAST scores were lower in euthymic (18.55 ± 13.19; F = 35.43; p < 0.001) patients, as compared with manic (40.44 ± 9.15) and depressive patients (43.21 ± 13.34). The FAST showed strong psychometrics properties and was able to detect differences between euthymic and acute BD patients. In addition, it is a short (6 minutes) simple interview-administered instrument, which is easy to apply and requires only a short period of time for its application.

2 January 2019 in World Psychiatry
Verified
Journal Article
Open access
PDF file
GRGeoffrey M. Reed
Geoffrey M. Reed
MFMichael B. First
Michael B. First
CKCary S. Kogan
Cary S. Kogan
SHSteven E. Hyman
Steven E. Hyman
OGOye Gureje
Oye Gureje
SSShekhar Saxena
Shekhar Saxena
Following approval of the ICD‐11 by the World Health Assembly in May 2019, World Health Organization (WHO) member states will transition from the ICD‐10 to the ICD‐11, with reporting of health statistics based on the new system to begin on January 1, 2022. The WHO Department of Mental Health and Substance Abuse will publish Clinical Descriptions and Diagnostic Guidelines (CDDG) for ICD‐11 Mental, Behavioural and Neurodevelopmental Disorders following ICD‐11’s approval. The development of the ICD‐11 CDDG over the past decade, based on the principles of clinical utility and global applicability, has been the most broadly international, multilingual, multidisciplinary and participative revision process ever implemented for a classification of mental disorders. Innovations in the ICD‐11 include the provision of consistent and systematically characterized information, the adoption of a lifespan approach, and culture‐related guidance for each disorder. Dimensional approaches have been incorporated into the classification, particularly for personality disorders and primary psychotic disorders, in ways that are consistent with current evidence, are more compatible with recovery‐based approaches, eliminate artificial comorbidity, and more effectively capture changes over time. Here we describe major changes to the structure of the ICD‐11 classification of mental disorders as compared to the ICD‐10, and the development of two new ICD‐11 chapters relevant to mental health practice. We illustrate a set of new categories that have been added to the ICD‐11 and present the rationale for their inclusion. Finally, we provide a description of the important changes that have been made in each ICD‐11 disorder grouping. This information is intended to be useful for both clinicians and researchers in orienting themselves to the ICD‐11 and in preparing for implementation in their own professional contexts.

29 September 2015 in The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences
Verified
Journal Article
Open access
PDF file
NGNoé Garin
Noé Garin
AKAi Koyanagi
Ai Koyanagi
SCSomnath Chatterji
Somnath Chatterji
STStefanos Tyrovolas
Stefanos Tyrovolas
BOBeatriz Olaya
Beatriz Olaya
JHJosep Maria Haro
Josep Maria Haro
Population ageing challenges health care systems due to the high prevalence and impact of multimorbidity in older adults. However, little is known about how chronic conditions present in certain multimorbidity patterns, which could have great impact on public health at several levels. The aim of our study was to identify and describe multimorbidity patterns in low-, middle-, and high-income countries. We analyzed data from the Collaborative Research on Ageing in Europe project (Finland, Poland, and Spain) and the World Health Organization’s Study on Global Ageing and Adult Health (China, Ghana, India, Mexico, Russia, and South Africa). These cross-sectional studies obtained data from 41,909 noninstitutionalized adults older than 50 years. Exploratory factor analysis was performed to detect multimorbidity patterns. Additional adjusted binary logistic regressions were performed to identify associations between sociodemographic factors and multimorbidity. Overall multimorbidity prevalence was high across countries. Hypertension, cataract, and arthritis were the most prevalent comorbid conditions. Two or three multimorbidity patterns were found per country. Several patterns were identified across several countries: “cardio-respiratory” (angina, asthma, and chronic obstructive pulmonary disease), “metabolic” (diabetes, obesity, and hypertension), and “mental-articular” (arthritis and depression). A high prevalence of multimorbidity occurs in older adults across countries, with low- and middle-income countries gradually approaching the figures of richer countries. Certain multimorbidity patterns are present in several countries, which suggest that common underlying etiopathogenic factors may play a role. Deeper understanding of these patterns may lead to the development of preventive actions to diminish their prevalence and also give rise to new, comprehensive approaches for the management of these co-occurring conditions.

29 March 2006 in Social Psychiatry and Psychiatric Epidemiology
Verified
Journal Article
Closed access
PDF file
ODOdd Steffen Dalgard
Odd Steffen Dalgard
CDChristopher Dowrick
Christopher Dowrick
VLVille Lehtinen
Ville Lehtinen
JVJose Luis Vazquez-Barquero
Jose Luis Vazquez-Barquero
PCPatricia Casey
Patricia Casey
TGThe ODIN Group
The ODIN Group

4 January 2018 in PLOS ONE
Verified
Journal Article
Open access
PDF file
LRLaura Alejandra Rico-Uribe
Laura Alejandra Rico-Uribe
FCFrancisco Félix Caballero
Francisco Félix Caballero
NMNatalia Martín María
Natalia Martín María
MCMaria Cabello
Maria Cabello
JAJosé Luis Ayuso-Mateos
José Luis Ayuso-Mateos
MMMarta Miret
Marta Miret
Loneliness has social and health implications. The aim of this article is to evaluate the association of loneliness with all-cause mortality. Pubmed, PsycINFO, CINAHL and Scopus databases were searched through June 2016 for published articles that measured loneliness and mortality. The main characteristics and the effect size values of each article were extracted. Moreover, an evaluation of the quality of the articles included was also carried out. A meta-analysis was performed firstly with all the included articles and secondly separating by gender, using a random effects model. A total of 35 articles involving 77220 participants were included in the systematic review. Loneliness is a risk factor for all-cause mortality [pooled HR = 1.22, 95% CI = (1.10, 1.35), p < 0.001] for both genders together, and for women [pooled HR = 1.26, 95% CI = (1.07, 1.48); p = 0.005] and men [pooled HR = 1.44; 95% CI = (1.19, 1.76); p < 0.001] separately. Loneliness shows a harmful effect for all-cause mortality and this effect is slightly stronger in men than in women. Moreover, the impact of loneliness was independent from the quality evaluation of each article and the effect of depression.